We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+6.67%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+472.96%
AUM
$475B
AUM Growth
+$21.4B
Cap. Flow
-$8.62B
Cap. Flow %
-1.82%
Top 10 Hldgs %
17.9%
Holding
5,783
New
811
Increased
2,514
Reduced
1,655
Closed
342

Sector Composition

Rank Sector Weight
1 Financials 14.59%
2 Technology 12.2%
3 Healthcare 9.44%
4 Consumer Discretionary 8.6%
5 Industrials 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACRS icon
4401
Aclaris Therapeutics
ACRS
$868M
$124K ﹤0.01%
+5,015
New +$122K
ORC
4402
Orchid Island Capital
ORC
$1.3B
$124K ﹤0.01%
+2,678
New +$132K
NVEE
4403
DELISTED
NV5 Global
NVEE
$122K ﹤0.01%
9,064
+3,896
+75% +$52.9K
WF icon
4404
Woori Financial
WF
$17B
$122K ﹤0.01%
2,734
+2,500
+1,068% +$112K
SBBP
4405
DELISTED
Strongbridge Biopharma plc.
SBBP
$122K ﹤0.01%
+16,802
New +$105K
TELL
4406
DELISTED
Tellurian Inc.
TELL
$121K ﹤0.01%
+12,452
New +$133K
ATAXZ
4407
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$121K ﹤0.01%
20,007
-13,323
-40% -$80.6K
LJPC
4408
DELISTED
La Jolla Pharmaceutical Company
LJPC
$121K ﹤0.01%
+3,772
New +$123K
USAS
4409
Americas Gold and Silver
USAS
$1.73B
$120K ﹤0.01%
14,680
+5,640
+62% +$55.3K
OCUL icon
4410
Ocular Therapeutix
OCUL
$2.03B
$119K ﹤0.01%
26,827
-305,873
-92% -$1.56M
BCIC
4411
BCP Investment Corp
BCIC
$94.7M
$119K ﹤0.01%
+3,480
New +$120K
BREW
4412
DELISTED
Craft Brew Alliance, Inc.
BREW
$119K ﹤0.01%
6,173
+2,287
+59% +$42.9K
AKAO
4413
DELISTED
Achaogen Inc
AKAO
$119K ﹤0.01%
11,070
+7,370
+199% +$92.5K
GEOS icon
4414
Geospace Technologies
GEOS
$72.8M
$118K ﹤0.01%
9,127
-2,171
-19% -$33.5K
LULU icon
4415
PUT
lululemon athletica
LULU
$14.5B
$118K ﹤0.01%
+1,500
New +$100K
RESN
4416
DELISTED
Resonant Inc.
RESN
$118K ﹤0.01%
+15,753
New +$89K
NNA
4417
DELISTED
Navios Maritime Acquisition Corporation
NNA
$118K ﹤0.01%
7,047
-5,733
-45% -$108K
CID
4418
DELISTED
VictoryShares International High Div Volatility Wtd ETF
CID
$118K ﹤0.01%
3,258
+3,211
+6,832% +$115K
CVLG icon
4419
Covenant Logistics
CVLG
$850M
$117K ﹤0.01%
8,122
+76
+0.9% +$1.09K
EWX icon
4420
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$694M
$117K ﹤0.01%
2,250
IWL icon
4421
iShares Russell Top 200 ETF
IWL
$2.28B
$117K ﹤0.01%
1,900
JHMM icon
4422
John Hancock Multifactor Mid Cap ETF
JHMM
$6.11B
$117K ﹤0.01%
3,433
-1,455
-30% -$48.5K
MNOV icon
4423
MediciNova
MNOV
$65M
$117K ﹤0.01%
18,056
+13,180
+270% +$87.4K
NCSM icon
4424
NCS Multistage Holdings
NCSM
$132M
$117K ﹤0.01%
397
+253
+176% +$93.7K
TCRT icon
4425
Alaunos Therapeutics
TCRT
$4.84M
$117K ﹤0.01%
190
+189
+18,900% +$136K

Similar funds

JP Morgan Chase's Q4 2017 Portfolio in Review

As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

  • JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
  • JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
  • JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
  • JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
  • JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
  • JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
  • JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.

Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.